Programme


 SESSION ONE
8:30am

Mihi

Kimi Henare

Conference opening

Dr Kate Clarke

8:40am

Chair introduction

Dr Rachel Purcell

8:45am

Leveraging the gut microbiome for improving clinical outcomes in colorectal cancer

Mr James Kinross 

 SESSION TWO
9:25am

Chair introduction

Dr Anita Dunbier

9:27am

Biomed pharmac: Immune Modulation Restores Cancer-Induced Impairments in Skeletal Muscle Mitochondrial Response to Exercise Training in Mice

Linda Buss

9:32am

Biomed pharmac: Circulating SncRNAs as Diagnostic and Predictive Biomarkers for Colorectal Cancer

Annabelle Greenwood

9:37am

Biomed pharmac: Gene expression variability phenotype in breast tumours from BRCA1 pathogenic variant carriers

George Wiggins

9:42am

Biomed pharmac: Pseudokinase Tribbles Homolog 1 regulates breast cancer cell proliferation via specific protein-protein interactions that modulate key transcription factors 

Hamish Mcmillan

9:47am

Chair introduction

Dr Alvin Tan

9:49am

Clinical pharmac: Cancer And Blood Department, Retrospective analysis of the role of chemotherapy in early invasive lobular breast cancer 

Dr Annie Manning

9:54am

Clinical pharmac: Development of an open-source immune scoring system for assessing complex immune infiltrate in colorectal cancer patients 

Dr Janet Rhodes

9:59am

Clinical pharmac: Financial outcomes in people with neuroendocrine tumours in New Zealand

Dr Gwen Pinches

10:04am

Clinical pharmac: Identifying New Zealand Early Breast Cancer Patients who would most benefit from a Multigene Assay

Dr Lauren Brown

10:10amBreak | Posters | Exhibitors
 SESSION THREE
10:30amRoche welcome and video
10:35am

Roche Award  - 2020 Award | 2019 recipient report back

Visualising dynamic interactions of antigen presentation machinery in gastric cancer

Dr Sharon Pattison

10:55am

Chair introduction

Dr Aniruddha Chatterjee

11:00am

Predictive biomarkers for immune checkpoint inhibitors in melanoma

Professor Helen Rizos 

11:40am

Chair introduction

Dr Aniruddha Chatterjee

11:42am

Circulating tumour cells as a model to identify tumour-specific epigenetic signatures of colorectal cancer metastasis

Sai Shyam Vasantharajan 

11:52am

Peroxidasin expression and activity in invasive metastatic melanoma

Dr Martina Paumann-Page

12:02pm

Opportunities to combine cancer research studies – a role for NZSO

A/Prof Roslyn Kemp 

12:12pm

Chair introduction

Dr Nicky Lawrence

12:17pm

Teletrial model for enhancing clinical trial access and recruitment

Professor Sabe Sabeson

1:00pmBreak | Posters | Exhibitors
 SESSION FOUR
1:40pmOncoSil welcome and video
1:45pm

Patient Understanding and Perspectives of DNA Testing for Cancer – Consideration in Implementation of a Cancer Genomic Programme in Auckland

Nathaniel Li 

1:55pm

Copy number variants as modifiers of breast cancer risk for BRCA1 and BRCA2 pathogenic variant carriers

Dr Christopher Hakkaart

2:05pm

Lutetium-177-PSMA I&T for progressing metastatic castrate-resistant prostate cancer: A single NZ centre experience

Madhusudan Vyas

2:15pm

Chair introduction

Dr Kate Clarke

2:20pm

Te Aho o Te kahu

Professor Di Sarfati

2:50pmBreak | Posters | Exhibitors
 SESSION FIVE
3:10pmMSD welcome and video
3:15pm

Bruce Cain Memorial Introduction 

Dr Rachel Purcell

3:20pm

Bruce Cain memorial lecture: Addressing the gaps in evidence for prevention of rarer cancers and cancers with long lead times

Professor Terry Dwyer 

3:50pm

NZSO Translational research award introduction

Associate Professor Margaret Currie

3:55pm

NZSO Translational research award lecturer

Professor Mike Eccles

4:25pmAward presentations
4:45pmClose
4:45pmAGM